EVH
Evolent Health, Inc. · Healthcare · Medical - Healthcare Information Services
Momentum inputs (comparable managers):
holder breadth +7.7% ·
share flow -8.0% ·
net new positions +7.1%
· formula
Ownership fragmentation: more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | +6 | 70.64M | $382.54M | +11 | −4 |
| Q1 2026 | 73 | -12 | 65.20M | $148.81M | +7 | −20 |
| Q4 2025 | 86 | 0 | 77.77M | $307.90M | +1 | n/a |
| Q3 2025 | 19 | +1 | 60.10M | $508.46M | +2 | −2 |
| Q2 2025 | 16 | -1 | 36.98M | $416.34M | n/a | −1 |
| Q1 2025 | 14 | 0 | 22.70M | $214.97M | +1 | −1 |
| Q4 2024 | 14 | +1 | 27.38M | $247.73M | +1 | n/a |
| Q3 2024 | 12 | 0 | 21.00M | $593.78M | +1 | −1 |
| Q2 2024 | 12 | n/a | 19.79M | $378.42M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 10.44M | -17.1% | $117.41M | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 2 | State Street Global Advisors ✦ (passive) | 8.76M | n/a | $38.26M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 3 | Geode Capital Management ✦ (passive) | 2.51M | -0.3% | $28.29M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 4 | Millennium Management ✦ | 1.26M | +198.7% | $14.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Norges Bank ✦ (passive) | 1.11M | -17.4% | $12.52M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Adage Capital Partners ✦ | 844.50K | -40.5% | $9.50M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 744.45K | +4.0% | $8.38M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | D. E. Shaw & Co. ✦ | 623.07K | New | $7.01M | 0.0% | New | 1 | SEC ↗ ×2 |
| 9 | Citadel Advisors ✦ | 482.02K | +142.9% | $5.42M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 281.14K | -81.2% | $3.16M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | GAMCO Investors ✦ | 197.10K | +43.8% | $2.22M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Marshall Wace ✦ | 94.32K | +45.1% | $1.06M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 13 | Bridgewater Associates ✦ | 21.12K | -70.9% | $237,578 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 11.95K | +66.2% | $134,484 | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| D. E. Shaw & Co. | $7.01M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 7.50M shares, $3.77M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 65.89K sh · $329,460
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology